Dr Reddy’s recalls 50k bottles of Ondansetron tabs in US
The ongoing recall was initiated on March 30, 2016
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
US FDA
Pharma exports growth heading for a sharp decline: CRISIL Research
As game changes, companies need to redraw long-term strategies and focus on innovation
Pfizer signs definitive merger agreement with Anacor Pharmaceuticals
To acquire Anacor Pharmaceuticals for $5.2 billion
Pfizer and Anacor Pharmaceuticals have entered into a definitive merger…
Aurobindo Pharma gets US FDA nod for anaesthetic injection
The product is expected to be launched in the second quarter of 2016-17 fiscal, it added
Embracing quality as an opportunity
Concerned with declining pharma exports in the recent past, the Ministry of Commerce & Industry has tried to burnish the brand…
Alembic Pharma receives FDA observations for Panelav plant
The company, however, did not provide any details about the observations
Pharma sector likely to report good growth for Q4 of last fiscal
According to a report in Centrum Broking, the domestic pharma market will gain from price increase, volume growth and new product…
Sun Pharma receives US FDA approval for BromSite
First NSAID approved for prevention of ocular pain in patients undergoing cataract surgery
Glenmark receives US FDA approval for bendamustine hydrochloride injection
It is Glenmark’s first injectable approval in the US
Indoco Remedies receives USFDA nod for solid dosages plant I in Goa
The plant has a capacity to manufacture 2.2 billion tablets, 32 million bottles of liquid orals, 16 million tubes of creams and…